Disease | ovarian cancer |
Symptom | C0029896|ent disease |
Sentences | 9 |
PubMedID- 24616882 | Response rates (rr) of 31–40% have been reported in gbrcam ovarian cancer patients with measureable recurrent disease, and the rr and duration of response to parpi monotherapy has been associated with platinum sensitivity (6, 7). |
PubMedID- 22967087 | The results of our study indicate that presence of two aberrations in tp53 on 17p and loh on 19q in early stage serous ovarian cancer is associated with recurrent disease. |
PubMedID- 21045830 | Sebastian et al (2008) retrospectively evaluated the diagnostic utility of ct scanning in 51 ovarian cancer patients with recurrent disease. |
PubMedID- 23251472 | Thus, standard chemotherapy is largely non-beneficial for intrinsically chemoresistant ovarian cancer patients (with persistent or recurrent disease within 6 months). |
PubMedID- 20182637 | Since current trials have focused on all ovarian cancer patients with advanced/recurrent disease, there may also be a future role for targeting a specific subset of the patient population based on tumor biomarkers. |
PubMedID- 23347343 | We have hence extended our phase i trial to include the evaluation of mv-nis as a single agent (108 and 109 tcid50 per dose, 6 cycles) in ovarian cancer patients with recurrent disease . |
PubMedID- 22709648 | Background: for recurrent disease or primary therapy of advanced ovarian cancer, cytoreductive surgery (crs) followed by adjuvant chemotherapy is a therapeutic option. |
PubMedID- 23663277 | Unfortunately, clinical response to second-line therapy is usually short-lived, and women with recurrent disease will die of ovarian cancer . |
PubMedID- 25552305 | We sought to report incidence, risk factors, and survival related to bowel obstruction in 311 ovarian cancer patients with recurrent disease. |
Page: 1